Results 31 to 40 of about 8,261 (192)

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile

Frontiers in Public Health, 2023
IntroductionSevere acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 million ...
Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Loredana Arata, Jonnathan Grossolli, Boris Riveros-Rodriguez, Luis Ardiles, Julio Santelises, Julio Santelises, Valeria Vasquez-Saez, Daniel F. Escobar, Daniel Soto, Cecilia Canales, Janepsy Díaz, Liliana Lamperti, Daniela Castillo, Mychel Urra, Felipe Zuñiga, Valeska Ormazabal, Estefanía Nova-Lamperti, Rosana Benítez, Alejandra Rivera, Claudia P. Cortes, Claudia P. Cortes, Claudia P. Cortes, María Teresa Valenzuela, Heriberto E. García-Escorza, Abel E. Vasquez, Abel E. Vasquez, Abel E. Vasquez   +30 more
doaj   +1 more source

Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases

Human Vaccines & Immunotherapeutics, 2023
The mRNA-based BNT162b2 and inactivated whole-virus CoronaVac are two widely used COVID-19 vaccines that confer immune protection to healthy individuals. However, hesitancy toward COVID-19 vaccination appeared to be common for patients with neuromuscular
Michael Kwan Leung Yu, Sophelia Hoi Shan Chan, Samuel Cheng, Daniel Leung, Sau Man Chan, Amy Suen Ka Yan, Wilfred Hing Sang Wong, Malik Peiris, Yu Lung Lau, Jaime S Rosa Duque   +9 more
doaj   +1 more source

Anti-SARS-CoV-2 spike receptor binding domain (S-RBD) IgG antibodies following CoronaVac administration: a longitudinal study. Anti-SARS-CoV-2 S-RBD IgG antibodies

Медицинская иммунология, 2023
Reports on antibody titers following CoronaVac administration are still scarce, particularly when it comes to the post-vaccination effectiveness of CoronaVac in the Indonesian population.
Ph. Liana, S. Fertilita, E. Amalia, V. Larasati, R. S.P. Rasyid, E. F. Zulissetiana, R. Sabloak, Z. U. Sari   +7 more
doaj   +1 more source

ANCA-associated vasculitis following the CoronaVac vaccination

Therapeutic Advances in Chronic Disease, 2022
With the coronavirus disease 2019 (COVID-19) pandemic, vaccination has become one of the cornerstones to contain the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Large clinical trials have shown high efficacy and safety of SARS-CoV-2 vaccination against COVID-19.
Yaohui Ma, Tianlun Huang, Gaosi Xu
openaire   +3 more sources

Dermatological adverse effects of COVID-19 vaccines

Turkderm Turkish Archives of Dermatology and Venereology, 2022
Studies for vaccine development have been completed in an unprecedented time to prevent further outbreak of the dangerous and potentially fatal coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2 ...
Elçin Akdaş, Nilsel İlter
doaj   +1 more source

CoronaVac Chile

, 2021
Dataset of tweets about CoronaVac in ...
Patricio Ramírez-Correa (11387177)
core   +1 more source

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine [PDF]

, 2022
OBJECTIVE: Despite the high vaccine efficacy of mRNA COVID‐19 vaccines, there are individuals who developed excessive reactogenic and/or allergic responses after the first mRNA dose and were considered ineligible for further mRNA doses.
Jean‐Marc Chavatte, Matthew Zirui Tay, Zi Wei Chang, Poh Lian Lim, Surinder Pada, Chavatte, JM, Fong, Siew-Wai, Yong Jie Tan, Pei Xiang Hor, Raymond TP Lin, Loh, CY, Zhuo, NZ, Tan, Yong Jie, Ong, DLS, Ngoh, EZX, Yee‐Sin Leo, Salleh, Siti Nazihah Mohd, Pada, Surinder, Somani, J, Ren, EC, Tay, Matthew Zirui, Renia, L, Siew‐Wai Fong, Lye, DC, Eng Sing Lee, Lye, David C, Angeline Rouers, Barnaby Edward Young, Rouers, A, Fong, Siew‐Wai, Wang, B, Wang, CI, Young, Barnaby Edward, Joel Xu En Wong, Raphael Tze Chuen Lee, Zhuo, Nicole Ziyi, Lee, ES, Chiew Yee Loh, Tay, MZ, Lee, RTC, Bei Wang, Leo, YS, Wang, Cheng‐I, Daniel Rui Xiang Lim, Goh, Yun Shan, Sun, LJ, Renia, Laurent, Chang, ZW, Pada, S, Lim, PL, Laurent Renia, Chavatte, Jean-Marc, Loh, Chiew Yee, Maurer-Stroh, S, Chang, Zi Wei, Lim, Daniel Rui Xiang, Ngoh, Eve Zi Xian, Ng, LFP, Rouers, Angeline, Wang, Bei, Chavatte, Jean‐Marc, Sun, Louisa Jin, Jyoti Somani, Ng, Lisa FP, Lee, Eng Sing, Yuling Huang, Wong, Joel Xu En, Hor, PX, Wong, JXE, Sebastian Maurer‐Stroh, Maurer‐Stroh, Sebastian, Tan, YJ, Young, BE, Leo, Yee-Sin, Ee Chee Ren, Siti Nazihah Mohd Salleh, Desmond Luan Seng Ong, Yun Shan Goh, Somani, Jyoti, Lin, Raymond TP, Salleh, SNM, Eve Zi Xian Ngoh, Lee, Raphael Tze Chuen, Ren, Ee Chee, Maurer-Stroh, Sebastian, Nicole Ziyi Zhuo, Fong, SW, Lim, Poh Lian, Lim, DRX, Lisa FP Ng, Ong, Desmond Luan Seng, Huang, Y, Hor, Pei Xiang, David C Lye, Louisa Jin Sun, Lin, RTP, Wang, Cheng-I, Huang, Yuling, Leo, Yee‐Sin, Cheng‐I Wang, Goh, YS   +100 more
core   +1 more source

Immunoglobulin G and neutralizing antibody response after CoronaVac. [PDF]

Rev Assoc Med Bras (1992)
SUMMARY OBJECTIVE: The aim of this study was to evaluate the kinetics of immunoglobulin G and neutralizing antibody responses following vaccination with CoronaVac in healthcare professionals. METHODS: A cohort of 35 healthcare professionals was recruited, and blood samples were collected to assess immunoglobulin G detection and neutralizing ...
Assis PBC, Ferreira LN, Magalhães FMV, Távora PF, Santos LID.   +4 more
europepmc   +4 more sources

Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients

BMC Medicine, 2022
Background In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated (CoronaVac) and mRNA (BNT162b2) COVID-19 vaccines using a population-based
Carlos King Ho Wong, David Tak Wai Lui, Xi Xiong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Ching Lung Cheung, Chi Ho Lee, Yu Cho Woo, Ivan Chi Ho Au, Matthew Shing Hin Chung, Franco Wing Tak Cheng, Kathryn Choon Beng Tan, Ian Chi Kei Wong   +14 more
doaj   +1 more source

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

Vaccines, 2022
In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford ...
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn, Supaporn Phumiamorn   +24 more
doaj   +1 more source